EBV Infection in XLP1 Manifested Solely by Behavioral Aggression and Effective Treatment Using Rituximab
Patients with X-linked lymphoproliferative disease 1 (XLP1) are exquisitely susceptible to Epstein-Barr virus (EBV), with the first EBV infection often resulting in rapid death. In a manner not previously described, a 5-year-old patient with XLP1 presented solely with behavioral aggression, with no...
Main Authors: | Michelle M. Korah-Sedgwick, Luke A. Wall |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Case Reports in Immunology |
Online Access: | http://dx.doi.org/10.1155/2018/3705376 |
Similar Items
-
Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
by: Umaimainthan Palendira, et al.
Published: (2011-11-01) -
Cellular studies on the pathogenesis of X-linked lymphoproliferative (XLP) syndrome
by: Sharifi, G.
Published: (2005) -
Successful Treatment of Posttransplant EBV-Associated Lymphoma and Plasmacytoma Solely Localized to the CNS
by: Per Boye Hansen, et al.
Published: (2012-01-01) -
Pharmacological characterisation of the hP2Y₁₁ and XlP2Y₁₁ receptors
by: Drew, Christian Michael
Published: (2006) -
The Natural History of X-Linked Lymphoproliferative Disease (XLP1): Lessons from a Long-Term Survivor
by: Yike Jiang, et al.
Published: (2020-01-01)